Conference Coverage

Effective osteoarthritis therapy remains elusive


 

EXPERT ANALYSIS FROM RWCS 2020

On a brighter note

Radiofrequency ablation and neuromodulation procedures for treatment of symptomatic knee OA make no pretense of being disease modifying, but a new systematic review of 33 published studies deemed of moderate or high methodological quality totaling 1,512 patients documented improved pain, function, and disease-specific quality of life for 3-12 months with minimal complications.

Most of these procedures target the genicular nerve, the sensory nerve that innervates the knee.

“There’s some value here to this,” Dr. Ruderman said. “Our pain folks are actually pretty interested in this. At our center, they’re using this for patients with persistent knee pain after knee replacement, with some success. It’s not an unreasonable approach.”

As part of his examination of the evidence base for OA treatment, Dr. Ruderman looked into an intervention he wasn’t familiar with: acupuncture. He was pleasantly surprised.

“There’s quite a bit of data. There is decent evidence that acupuncture has significant benefit, at least for pain, and is certainly without significant side effects,” according to the rheumatologist.

He cited a review of a dozen systematic reviews of randomized, controlled trials of acupuncture for OA. The Chinese investigators rated the overall quality of the evidence as moderate to low, but with some studies being rated high quality. “That’s not as bad as some of the other stuff I looked at,” Dr. Ruderman said.

Acupuncture was found to be 2.4 times more effective than Western medicine for short-term pain relief, and 4.1 times better in terms of total efficacy, with a lower risk of adverse events than with Western medicine.

Dr. Ruderman reported serving as a consultant for and/or receiving research grants from more than a half-dozen pharmaceutical companies.

Pages

Recommended Reading

Cannabidiol may interact with rheumatologic drugs
MDedge Rheumatology
Consider centralized pain in patients with rheumatic disease
MDedge Rheumatology
Cannabinoids, stem cells lack evidence for osteoarthritis, expert says
MDedge Rheumatology
Methotrexate may affect joint erosions but not pain in patients with erosive hand OA
MDedge Rheumatology
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
MDedge Rheumatology
Tanezumab posts higher safety event rate than NSAIDs over 1 year in hip, knee OA
MDedge Rheumatology
Well-tolerated topical capsaicin formulation reduces knee OA pain
MDedge Rheumatology
Prednisolone scores for hand OA
MDedge Rheumatology
Prescription osteoarthritis relief gets OTC approval
MDedge Rheumatology
Joint replacement: What’s new in 2020
MDedge Rheumatology